|
CN112279907A
|
|
Purification method of somaglutide
|
|
CN112285217A
|
|
Ultra-high performance liquid chromatography analysis method of Somalutide
|
|
CN112279895A
|
|
Preparation method of chemically synthesized acidic polypeptide
|
|
CN112125956A
|
|
Preparation method of degarelix
|
|
CN111057141A
|
|
Tripeptide refining process
|
|
CN112010961A
|
|
Solid-liquid synthesis method of somaglutide
|
|
CN111944037A
|
|
Synthetic method of somaglutide
|
|
CN111944039A
|
|
Synthetic method of somaglutide
|
|
CN111944038A
|
|
Synthetic method of somaglutide
|
|
CN111035764A
|
|
Composition for treating rheumatoid arthritis and preparation method thereof
|
|
CN111036078A
|
|
Post-treatment method of GnRH antagonist
|
|
CN110191892A
|
|
Alanine-lysine-glutamic acid tripeptide derivative and its application
|
|
CN110386964A
|
|
A kind of solid-liquid synthetic method of Leuprorelin
|
|
WO2019113872A1
|
|
Method for synthesizing linaclotide
|
|
WO2018032521A1
|
|
Method for synthesizing liraglutide
|
|
CN106110306A
|
|
A kind of teriparatide nasal-cavity administration Liposomal formulation and preparation method thereof
|
|
CN105832691A
|
|
Dulaglutide colon positioning sustained release preparation and preparation method thereof
|
|
CN107108706A
|
|
Snake venom C Fragment Polymorphism derivatives
|
|
CN105535933A
|
|
Leuprorelin medicinal composition injection type hypodermic implantation agent
|
|
WO2017113086A1
|
|
Snake venom c polypeptide fragment and analgesic drug
|
